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Unusual expression of human lymphocyte antigen class II
in normal renal microvascular endothelium
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Unusual expression of human lymphocyte antigen class II in mune disorders and allograft rejection. Products of HLA
normal renal microvascular endothelium. class II genes present peptides derived from exogenous
Background. The human lymphocyte antigen (HLA) class proteins to CD41 T cells and are constitutively expressedII proteins (DR, DQ, and DP) and DM, a protein involved in
on only a few cells, such as dendritic cells, B lymphocytes,loading antigenic peptide onto the class II molecules, have a
and macrophages. Class II expression can also be inducedcoordinate regulation that facilitates antigen presentation to
CD41 T cells. CIITA is a specific transcription factor responsi- in most other cells with g-interferon (g-IFN) [1].
ble for the coordinate regulation of these genes. DR expression Newly synthesized HLA class II proteins acquire anti-
in the kidney was described to be constitutive on renal micro- genic peptides in a highly regulated process as they tran-vascular endothelium in the early 1980s, but expression of other
sit to the cell surface. A nonpolymorphic protein knowngenes involved in class II antigen presentation (DQ, DP, DM,
as invariant chain becomes bound to HLA class II mole-and CIITA) has not been characterized.
Methods. Expression of the HLA class II proteins, DM, cules in the endoplasmic reticulum where it prevents
and CIITA in normal human kidney cortex was evaluated by premature binding of peptide [2, 3]. As the class II-
immunofluorescence microscopy, Northern blots, and reverse
invariant chain complex moves through the cell to thetranscriptase-polymerase chain reaction (RT-PCR).
plasma membrane, invariant chain is proteolyticallyResults. The endothelium of glomerular and peritubular
capillaries constitutively express DR, as indicated by colocali- cleaved [4, 5]. Remnant invariant chain is removed from
zation of DR and CD31 antibodies. However, the endothelium class II molecules by HLA-DM, allowing the binding of
of larger renal blood vessels is devoid of class II proteins. antigenic peptides derived from endocytosed proteins
Capillaries that express DR do not have detectable DQ, DP,
[6–9]. Peptide binding occurs within a lysosomal com-or DM by immunofluorescence. Northern blots identified DR,
partment designated MIIC [2, 3, 5, 10, 11]. DM is com-DP, and DM mRNAs but not DQ mRNA. CIITA was ampli-
fied by RT-PCR at a level that could account for the class II posed of two minimally polymorphic subunits, DMa and
expressed by the microvascular endothelium. DMb, encoded within the major histocompatibility com-
Conclusion. The renal microvascular endothelium constitu- plex (MHC). The class II molecules loaded with anti-tively expresses DR without the other class II proteins or DM.
genic peptides are then transported to the cell surfaceThis discoordinate expression of HLA class II genes is unusual
where they encounter CD41 T cells.and may contribute to the kidney’s ability to control CD41
T-cell responses. A major site of regulation for the genes required for
class II antigen presentation is at the level of transcrip-
tion. DR, DP, DQ, and DM are coordinately transcribed
The human lymphocyte antigen (HLA) locus controls because of common promoters and transcription factors.
immune responses by encoding the genes responsible for The transcription factor CIITA is found only in cells
presentation of antigenic peptides to T cells. Regulating expressing class II and is considered to be a specific
the expression of the HLA genes therefore has the poten- transcription factor for class II genes [12–15]. CIITA,
tial for augmenting the immune system against infection which is induced with g-IFN, has been shown to be the
and tumors and suppressing immune responses in autoim- specific g-IFN–inducible factor responsible for induced
class II expression. CIITA does not bind DNA but inter-
acts with three other DNA binding factors required for
Key words: major histocompatibility, gene expression, CIITA tran-
class II expression: RFX-5 [15], RFXANK [16], andscription factor, immune system, antigen presentation, DR expression,
CD41 T cells. RFXAP [17]. These DNA-binding proteins recognize
sequences within the promoter regions of the class IIReceived for publication March 23, 2000
genes, and although they are required for class II expres-and in revised form July 13, 2000
Accepted for publication August 10, 2000 sion, they are also present in cells that do not express
class II proteins.Ó 2001 by the International Society of Nephrology
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Human lymphocyte antigen class II expression in the Rockford, IL, USA), concentrated and conjugated to
kidney was described to be constitutive on peritubular fluorescein isothiocyanate (FITC), Alexa 568 (Molecular
and glomerular capillary endothelium in the early 1980s Probes, Eugene, OR, USA), or digoxigenin (Boehringer
[18–21], based on observations of DR protein localiza- Mannheim, Indianapolis, IN, USA) using manufactur-
tion with single antibody histochemical labeling. The er’s protocols. Polyclonal rabbit anti-DMb raised against
location of DR was assigned on the basis of association a 24mer peptide (Bio-Synthesis, Inc., Lewisville, TX,
with morphological structures rather than with colocali- USA) was affinity purified using a peptide-coupled
zation with antibodies specific for cell markers. Later, SulfoLink column (Pierce) [37]. Polyclonal rabbit anti-
Muller et al examined the normal distribution of DR, DM raised against both a and b chains was a kind gift
DP, and DQ in human kidney by immunohistochemical of Dr. Dennis Zaller (Merck, Inc., Rahway, NJ, USA).
techniques using intracellular alkaline phosphatase as a Monoclonal antibodies CD31-FITC and CD74-FITC
marker for endothelial cells [22]. It was difficult to local- were purchased from Immunotech, Inc. (Fullerton, CA,
ize precisely class II antibody staining with the alkaline USA) and Pharmingen (San Diego, CA, USA), respec-
phosphatase, and it was ambiguous whether class II was tively. Monoclonal antibodies 14.4.4S against murine
expressed in normal proximal tubular cells. I-E, Y3P against Iab, and MECA-32 [38] against murine
Human lymphocyte antigen class II expression in kid- endothelial cells were kindly provided by Dr. Andrew
neys has also been evaluated under conditions of acute Farr (University of Washington, Seattle, WA, USA).
rejection [23–26] and glomerulonephritis [22, 27–29], Anti-digoxin-Cy5 and -FITC were purchased from Jack-
again with single antibodies and histochemical labeling son ImmunoResearch (West Grove, PA, USA); other
techniques. The consistent observation is that HLA class secondary antibodies were purchased from Sigma (St.
II protein expression is induced on proximal tubular cells Louis, MO, USA).
in inflammatory states, such as acute rejection, rapidly
progressive glomerulonephritis, and membranoprolifer- Microscopy
ative glomerulonephritis. The class II isotype expressed Normal human kidney cortex was obtained from ne-
is not pathonomonic and probably reflects a generalized phrectomies performed for renal cell carcinoma. Normal
induction of class II via g-IFN. In vitro assays of tubular human lymph nodes were obtained from a liver donor
cells induced to express class II show that the cells are in the course of organ procurement. Tissue from renal
capable of antigen processing and peptide presentation, transplants with acute rejection was obtained from
but they lack the necessary costimulatory proteins re- biopsy material not needed for diagnosis. C57BL/6 and
quired for T-cell proliferation [27, 30–33] and hence may
BALB/c murine kidneys were generously provided by
contribute to tolerance or a state of anergy.
Dr. Andrew Farr (University of Washington). BlocksThe early investigations of HLA class II expression
of tissue were frozen in Tissue-Tek O.C.T. Compoundin the kidney predate our current understanding of class
(Sakura Finetek USA, Inc., Torrance, CA, USA) in aII structure, regulation, and antigen presentation. In the
dry ice-ethanol bath and stored at 2708C. Six micrometerpresent study, we re-examined HLA class II expression
cryostat sections were air dried, fixed in cold acetone, andin normal kidney by immunofluorescence and confocal
then labeled in saturating concentrations of antibody.microscopy and found that the microvascular endothe-
Phosphate-buffered saline (PBS) containing 1% bovinelium of peritubular and glomerular capillaries constitu-
serum albumin (BSA) was used as diluent and washtively express DR, but not the other class II isotypes or
solution. Primary antibody incubations were for oneDM. This is an unusual expression pattern for class II
hour in a humidified chamber; secondary antibody, ifproteins in light of the common regulation of the genes.
needed, was applied for 30 minutes. Sections wereSince CIITA is considered to be the specific transcription
mounted in Vectashield containing DAPI (Vector Labo-factor required for all class II gene expression, one would
ratories, Inc., Burlingame, CA, USA). Slides were exam-expect all the class II genes to be transcribed and ex-
ined using a Nikon Eclipse TE200 inverted microscopepressed when CIITA is present. The selective expression
equipped with epifluorescence. Data were digitally re-of DR in the kidney microvasculature indicates an un-
corded using a Photometrics SenSys CCD camera drivenusual regulation of class II that may contribute to the
by IPLab Spectrum software (Signal Analytics Corp.,kidney’s ability to respond to foreign antigens.
Vienna, VA, USA). A BioRad MRC 600 scanning laser
confocal microscope was used for confocal microscopy
METHODS (W.M. Keck Center for Advanced Studies in Neural
Antibodies Signaling, University of Washington; Fig. 6 c, e, f). Split-
image confocal files were merged with PIC.merge soft-Monoclonal antibodies L243 (anti-DR [34]), SPVL-3
ware, available from NIH-image (www.rsb.info.nih.gov/(anti-DQ [35]), and B7/21 (anti-DP [36]) were purified
from supernatant or ascites on protein A columns (Pierce, nih-image).
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Northern blots exons and generated a 711 bp product. GAPDH was
amplified as an internal control using primers fromTotal RNA was isolated from normal kidney tissue
Stratagene (catalog number 302047) that generated aby cesium chloride gradients [39], and Northern blots
600 bp product.were prepared by standard techniques [40]. Total RNA
was isolated similarly from uninduced and g-IFN–
induced ThM cells, derived from a melanoma [37], to RESULTS
serve as negative and positive controls, respectively.
DR expressionReverse transcriptase-polymerase chain reactions (RT-
DR is expressed on the endothelium of glomerular cap-PCRs) were used to generate cDNAs specific for HLA
illaries and peritubular microvasculature, but not on theclass II a subunits, DMa, DMb, invariant chain, and
endothelium of larger renal vessels. Normal kidney wasglyceraldehyde 3-phosphate dehydrogenase (GAPDH).
labeled with fluorophore-conjugated antibodies to thecDNAs were radiolabeled with 32P-dCTP using random
HLA class II protein DR and to CD31, a marker ofprimers (Boerhinger Mannheim kit #1004760) for hy-
endothelial cells [41]. CD31 was detected on the endo-bridization to Northern blots. GAPDH primers were
thelium of blood vessels of all sizes, including peritubularpurchased from Stratagene (La Jolla, CA, USA). Prim-
and glomerular capillaries. L243, an antibody to a mono-ers for DRA, DMA, DMB, and invariant chain amplified
morphic determinant of DR, colocalized with anti-CD31full-length cDNAs. Primers for DQA and DPA were
in peritubular capillaries of the interstitium (Fig. 1a–c)chosen to amplify cDNAs that would distinguish the
and within glomerular capillaries (Fig. 1d–f), but not inthree class II subtypes and generated cDNAs that were
larger blood vessels (Fig. 1g–i). Although the majority ofshorter than full-length sequences. Primer sequences for
cells expressing DR in normal kidney were of endothelialDQA were 59-GGTGTAAACTTGTACCAGT-39 and
origin as shown by their coexpression of CD31, occa-59-CTTGGTGTCTGGAAGCACCAA-39. Primer se-
sional cells expressing DR without CD31 were also iden-quences for DPA were 59-ATCAAGGCGGACCATGT
tified (Fig. 1j, k). The nonendothelial DR-expressingGTCAA-39 and 59-GGTCATGGCCAGAACGCAGA
cells included isolated cells within glomerular capillaryGACTTT-39.
loops (possibly circulating B lymphocytes or macro-
RT-PCR phages) and rare scattered interstitial cells. HB10.A, an-
other DR antibody, labeled tissue in a pattern identicalSingle-stranded cDNA was made from total RNA iso-
to that of L243 (data not shown). The expression of DRlated from normal kidney cortex using superscript pre-
on microvascular interstitial and glomerular endothelialamplification kit (Life Technologies catalog number 27-
cells, but not on the endothelium of larger vessels, was9255-02). PCR amplification was performed with Taq
observed for all normal kidney tissue from the eightpolymerase (Perkin Elmer, Roche, Branchburg, NJ,
kidneys that were examined.USA) for 55 cycles of 948C 3 30 seconds (denaturation),
458C 3 2 minutes (annealing), and 728C 3 1 minute
DQ and DP expression(extension). Primers used to amplify CIITA, 59-CCTG
DQ and DP are not expressed on the endothelium withATGCACATGTACTGGGC-39 and 59-ACGTCCATC
ACCCGGAGGGAC-39, were derived from different DR. The regulation of class II antigen-presenting genes
c
Fig. 1. DR expression in normal human kidney. DR is expressed on the endothelium of the peritubular microvasculature (b and c) and on
glomerular capillaries (e and f), but not on the endothelium of larger vessels (h and i). Rare scattered cells that express DR but not CD31 can be
found in the peritubular interstitium (j, arrow) and within glomerular capillary loops (k, arrow). Endothelial antibody CD31-FITC (green; a, d,
g, j, and k); DR antibody L243-Alexa 568 (red; b, e, h, j, and k); merged images (yellow indicates colocalization; c, f, i, j, and k) (a through i bar 5
50 mm; j and k bar 5 10 mm).
Fig. 2. DQ and DP expression in normal human kidney. Rare individual DQ or DP-positive cells can be found in the peritubular interstitium
(arrows, a and c) or in the glomerulus (G; arrows, b and d). DR antibody L243-digoxigenin (DIG) detected with anti-digoxin Cy5 (red; a–d); DQ
antibody SPVL-3-FITC (green; a and b); DP antibody B7/21-FITC (green; c and d; bar 5 50 mm).
Fig. 3. Colocalization of DQ, DP, and DR in a normal human lymph node germinal center. DQ antibody SPVL-3-FITC (green; a); DP antibody
B7/21-Alexa 568 (red; b); and DR antibody L243-DIG labeled with anti-digoxin Cy5 (blue; c). Colocalization of three colors is bluish white (d)
(bar 5 25 mm).
Fig. 4. Transplanted kidney with acute cellular and vascular rejection. Inflammation associated with acute rejection in a kidney transplant is
associated with induced expression of HLA class II proteins. In areas with tubulitis, tubules (T) and infiltrating leukocytes (L) express DQ (red;
b) and DR (blue; c) that colocalize (d, pink on merged images). DQ is also induced on peritubular endothelial cells (arrows in b) in areas of
inflammation. Colocalization of CD31, DQ, and DR on merged images appears bluish white (arrows in d). Endothelial cells are outlined and
colored light blue in e. Endothelial antibody CD31-FITC (green; a and d); DQ antibody SPVL-3-Alexa 568 (red; b and d); DR antibody L243-
DIG detected with anti-digoxin Cy5 (blue; c and d) (bar 5 50 mm).
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by common transcription factors predicts that a cell will
express all class II isotypes (DR, DP, and DQ) and DM
when any one of the class II molecules is present. How-
ever, this was not true for endothelial cells of the glomer-
ular capillaries, nor for the interstitial peritubular micro-
vasculature. Endothelium expressing DR did not have
detectable levels of DQ (Fig. 2a, b) or DP by immuno-
fluorescence microscopy (Fig. 2c, d). Results obtained
for DQ with the antibody SPVL-3 were confirmed with
1a3, another antibody that recognizes a monomorphic
DQ determinant (data not shown). In addition, labeling
with antibodies to CD31 and either DQ or DP failed to
show colocalization, indicating a nonendothelial location
of these HLA class II gene products (data not shown).
The selective DR expression on renal microvascular en-
dothelial cells without DQ and DP is unusual. To confirm
that the antibodies used for detecting class II proteins
in the kidney accurately identified DR, DQ, and DP
within tissue, sections from normal human lymph nodes
were examined. Germinal centers, which contain class
II expressing B lymphocytes, showed colocalization of
antibodies to DR, DQ, and DP (Fig. 3). In addition,
sections of a transplanted kidney with acute cellular and Fig. 5. Northern blot of HLA class II and related antigen-processing
genes in normal human kidney cortex. Identical blots containing 4 mgvascular rejection contained colocalized antibodies to all
each of total RNA derived from g-IFN–induced ThM (HLA class II-three HLA class II proteins in the infiltrating leukocytes positive melanoma cells, lane 1), uninduced ThM (HLA class II-nega-
and in tubules with induced class II expression. Figure tive melanoma cells, lane 2) and kidney cortex (lane 3) were hybridized
with the indicated probes DRA, DQA, DPA, DMA, DMB, invariant4 shows a section of rejecting kidney with DQ, DR, and
chain, and GAPDH.CD31 labeled. Under these inflammatory conditions, the
peritubular endothelium is induced to express DQ and
tubules express DR and DQ. The detection of HLA
class II proteins in the germinal centers of lymph nodes cence may reflect a post-transcriptional regulation of DP
and in allografts with acute rejection indicates that the that prevents DP protein expression or a relatively low
antibodies L243, SPVL-3, and B7/21 accurately detect abundance of DP protein compared with DR. DMA and
DR, DQ, and DP within tissue. The lack of labeling of DMB mRNAs in Northern blots of kidney cortex may
normal kidney with SPVL-3 and B7/21 indicates that originate from normal proximal tubular cells since cul-
DQ and DP are not expressed at levels detectable by tures of uninduced primary and transformed human
immunofluorescence, despite a common regulatory mech-
proximal tubular cells contain DMA and DMB mRNAs,
anism for the expression of class II genes.
but not mRNAs of the HLA class II genes (Muczynski,Differential expression of the HLA class II subtypes
unpublished results).was also evaluated by Northern blot analysis. RNA iso-
lated from normal renal cortical tissue of kidneys used Low expression of invariant chain and DM in normal
for immunofluorescence was hybridized to radiolabeled human kidney
cDNAs specific for HLA class II, DM, and invariant
Since invariant chain and HLA-DM are also requiredchain mRNAs. cDNAs for the b subunits of the class II
for HLA class II antigen presentation, we next examinedproteins share a significant amount of homology. Thus,
their expression in normal human kidney. Invariantnucleotide probes to the a subunits were used to distin-
chain was detected in scattered peritubular interstitialguish class II subtypes. DQA mRNA was not detected
cells expressing DR (Fig. 6d, e) and in some glomerularin normal kidney tissue (Fig. 5, lane 3), consistent with
capillaries (Fig. 6f). Antibodies to DM colocalized withthe lack of DQ protein by immunofluorescence. RNA
L243 on rare DR-expressing interstitial cells that did notfrom six different kidneys was evaluated, but none con-
express CD31 (Fig. 6a, b, g–j). Glomeruli did not containtained detectable DQA mRNA. Messenger RNAs for
detectable DM (Fig. 6c, h). The lack of DM and theDRA, DPA, DMA, DMB, and invariant chain were
presence of invariant chain on only a subpopulation ofpresent in Northern blots of whole cortical kidney (Fig.
DR expressing microvascular cells indicate that the usual5, lane 3). The low but detectable DPA mRNA com-
pared with the lack of detectable DP by immunofluores- antigen-presenting machinery described for professional
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Fig. 6. DM and invariant chain expression in normal human kidney cortex. DM was detected in scattered interstitial cells that also expressed DR
(arrows in a and b) but not CD31 (arrows in g–j). DM was not detected in glomeruli (c and h). Invariant chain was observed in a subset of
interstitial and glomerular cells that express DR (d–f). Rabbit DMb antiserum detected with goat anti-rabbit FITC (green; a–c); invariant chain
antibody anti-CD74-FITC (green; d–f); DR antibody L243-Alexa 568 (red; a–f); endothelial antibody anti-CD31-FITC (green; g and j); rabbit DM
antiserum raised against a and b chains detected with goat anti-rabbit TRITC (red; h and j); DR antibody L243-DIG detected with anti-digoxin
Cy5 (blue; I and j). In a–f, colocalization is yellow. In j, DM/DR colocalization is purplish pink; CD31/DR colocalization is turquoise (a and d bar
5 50 mm; b, c, e, and f bar 5 25 mm; g–j bar 5 50 mm).
antigen-presenting cells is not uniformly present in nor- pressing class II proteins. Its activity has been considered
to be essential for class II gene transcription, althoughmal human kidney microvascular endothelial cells.
a recent report describes a natural killer (NK) cell-medi-
CIITA, the specific class II transcriptional factor, ated, CIITA-independent mechanism of DRA expres-
is present in human kidney sion in endothelial cells [42]. CIITA mRNA is normally
present in very low abundance in class II-expressing cellsCIITA has been shown to be a specific, g-IFN–
inducible transcription factor present only in cells ex- such that it cannot be detected on Northern blots, but
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Fig. 7. RT-PCR amplification of CIITA, the specific HLA class II
transcription factor. CIITA was amplified from normal human kidney
cortex. Lanes 5 through 8 represent CIITA amplification from 30 to
120 mg of four different kidneys. Uninduced ThM cells were used as a
negative control (lane 1) and g-IFN was used to induce CIITA expres-
sion in ThM cells (positive control, lane 2). Semiquantitative results
show the abundance of CIITA in 5000, 500, or 50 g-IFN–induced ThM
cells (lanes 2, 3, and 4). GAPDH was used as a positive control for the
presence of intact mRNA sufficiently abundant to generate a PCR
product.
requires RT-PCR amplification for detection. Normal
cortical human kidney tissue was evaluated for the pres-
ence of CIITA by RT-PCR using primers that spanned
Fig. 8. MHC class II is expressed on nonendothelial cells in the murinedifferent exons. CIITA was amplified by RT-PCR from
kidney. Murine BALB/c kidney labeled for class II gene product I-E
all four kidneys evaluated (Fig. 7). Cultured ThM cells (murine DR equivalent) displayed a scattered dendritic pattern of renal
cortical label (a); the glomerulus (G) is negative for I-E (b). In C57BL/6with and without g-IFN induction were used as positive
kidney, another class II murine gene product, I-A, displayed a similarand negative controls, respectively, and as a means of
scattered dendritic pattern of renal cortical label (c); the glomerulus
obtaining semiquantitative information on CIITA abun- (G) is negative for I-A (d). Interstitial and glomerular capillary endothe-
lial cells are labeled in e and f, respectfully. I-E antibody 14.4.4S-DIGdance [37]. CIITA was amplified from 100 mg of kidney
(a and b); I-A antibody Y3P-DIG (c and d); and endothelial antibodycortex at a level equivalent to that present in at least MECA-32-DIG (e and f) were detected with anti-digoxin-FITC (a, c,
5000 ThM class II-positive cells (Fig. 7). Assuming the and e bar 5 50 mm; b, d, and f bar 5 25 mm).
amount of CIITA per cell is similar for both the ThM-
positive control cells and class II-expressing cells in the
kidney, 100 mg of kidney tissue contain an estimated
lonephritis in which glomerular inflammation has been5000 CIITA expressing cells. A 6 micron section of kid-
shown to be mediated by CD4 lymphocytes and depen-ney tissue weighing 200 mg contained approximately 4100
dent on class II and g-IFN expression [44–46]. NormalDR1 cells by visual inspection. Therefore, if CIITA is
murine kidney was re-examined for class II expressionresponsible for the expression of DR, immunofluores-
by immunofluorescence using the antibodies Y3P andcence microscopy estimates that 100 mg of kidney tissue
14.4.4S, which recognize the class II murine gene prod-should contain CIITA equivalent to 2050 class II-positive
ucts Iab and I-E, respectively. MECA-32 [38] was used tocells. The estimated number of cells containing CIITA
delineate murine endothelial cells (Fig. 8e, g). Scatteredamplified from whole kidney (5000) and that predicted
interstitial cells expressed MHC class II proteins I-Eto be present from an equivalent mass of tissue if the
(Fig. 8a) and I-A (Fig. 8c), but not in the microvascularDR in the tissue is due to CIITA (2050) are similar
pattern observed for human kidney. Murine glomeruli,(within the same order of magnitude). These data are
unlike those of humans, did not have detectable class IIconsistent with DR expression of the renal microvascula-
(Fig. 8b, d). These results are consistent with earlierture being mediated by CIITA.
published observations describing MHC class II expres-
Human kidney expresses DR on microvascular sion in the mouse as predominantly interstitial, on “den-
endothelial cells, whereas murine kidney expresses dritic” cells, and are very different from our observations
class II proteins on nonendothelial interstitial cells in human kidneys that class II proteins are expressed on
microvascular endothelial cells. If the cells expressingThe expression of DR on human endothelial cells
class II proteins in the kidneys of humans and mouse arewithin the interstitial microvasculature and glomeruli is
different, then conclusions drawn from murine modelsvery different from the pattern of MHC class II expres-
about class II immune mechanisms may have limitedsion described in the mouse kidney [43]. This difference
is pertinent in light of recent murine models for glomeru- applicability for human disease.
Muczynski et al: HLA class II in microvascular endothelium 495
DISCUSSION found in CIITA induced by g-IFN. Sequence variation
encoded by the first exon of CIITA could favor selectiveWe have confirmed the observation that normal hu-
transcription of DR over the other class II genes. An-man kidney constitutively expresses HLA class II pro-
other example of a class II transcription factor impartingteins, and by CD31 immunofluorescence colocalization,
differential expression of the class II genes comes fromwe have shown that the majority of cells expressing DR
a recent report of a RFX-5 mutation, which results inare endothelial cells. CD31 is also expressed on platelets
DR expression without DP or DQ [53]. This suggestsand leukocytes, but at very low levels compared with
that allelic differences in RFX5 could also allow for selec-endothelial cells [41]. The level of CD31 expression de-
tive DR expression. Further evaluation of selective DRtected in normal kidney and the pattern of labeling
expression in renal endothelium awaits purification ofwithin glomeruli and the interstitium are consistent with
the microvascular endothelial cells.that of capillaries rather than circulating platelets or leu-
Recent reports describe a CIITA-independent HLAkocytes.
class II expression on endothelial cells mediated by NKThe constitutive expression of DR on renal endothe-
cells [42, 54]. We considered such a mechanism for DRlial cells has two unusual features. First, expression is
expression in the renal microvasculature, but were un-limited to the microvasculature. The endothelium of
able to detect NK cell markers CD16 and CD56 in anylarger vessels does not contain DR. Second, DR is ex-
of the kidneys examined (data not shown). Althoughpressed without the other class II proteins. This is un-
this does not rule out a role for NK cells in the selectiveusual because of the common promoters for the class II
class II expression in the kidney, it makes it a less attrac-genes and DM, which for most cells result in a coordinate
tive model.transcription and expression of the gene products.
Endothelial cells in organs other than the kidney haveWe evaluated the mechanism for constitutive, but se-
been reported to express HLA class II proteins, primarilylective DR expression in the kidney by Northern blot
based on the expression of DR [55, 56]. Furthermore,analysis and by determining whether the specific class II
within the heart, expression of DR on the microvascula-
transcription factor, CIITA, was present. The limitation
ture but not on large vessel endothelial cells has been
of performing RNA analysis on whole tissue with the described [57–59]. The unusual HLA class II expression
presence of class II-expressing passenger leukocytes is in the kidney therefore may not represent unique immu-
recognized; however, this approach provided an initial nologic regulation.
step for correlating immunofluorescence observations We examined normal kidney tissue for the expression
with possible molecular mechanisms for class II expres- of DM and invariant chain, proteins required for class II
sion. DRA mRNA was detected in whole kidney, as antigen presentation. Messenger RNA for both proteins
expected from the presence of DR protein by immuno- was present in Northern blots of whole kidney, and scat-
fluorescence. DQA mRNA was not detected, which is tered DM and invariant chain cells were identified by
most likely due to lack of transcription of the DQA. DPA immunofluorescence. However, the DR-expressing mi-
mRNA was present in whole kidney, but DP protein was crovascular endothelial cells did not have detectable
not detectable by immunofluorescence. The apparent DM, and only a subpopulation of these cells expressed
discrepancy in DPA mRNA and protein expression invariant chain. Thus, it can be predicted that the class II-
might be explained by post-transcriptional regulation expressing endothelial cells of the kidney may function
that precludes DP translation (for example, rapid mRNA differently from professional antigen-presenting cells
degradation) or by a very low level of DP protein in such as dendritic cells, macrophages, and B lymphocytes.
normal kidney that is below the threshold level of detec- The lack of DM to facilitate peptide exchange for invari-
tion by immunofluorescence. CIITA cDNA was ampli- ant chain fragments suggests that peptides presented by
fied from normal whole kidney by RT-PCR and in microvascular endothelial DR in normal uninflamed kid-
amounts expected if DR expression in renal microvascu- ney would be derived primarily from invariant chain [59],
lar cells was mediated by CIITA. This suggests that DR and would not initiate an immune response since T cells
transcription in the kidney is due to the class II specific recognizing invariant chain peptides would have been
transcription factor. deleted during thymic selection. We have recently found
Regulatory controls for isotype specific class II expres- that certain class II molecules release invariant chain
sion could involve genes not yet known to be associated derived peptides without DM (T. Cotner, unpublished
with class II antigen presentation [47, 48], but it is possi- observations), which could allow peptides derived from
ble to speculate that selective class II expression could other endogenous proteins to be presented by microvas-
be mediated by CIITA or one of the other class II tran- cular endothelial cell DR.
scription factors. For example, CIITA has a tissue-spe- Human lymphocyte antigen presentation to a T cell of
cific variation in the first exon [49–52]. B cells and den- appropriate specificity will not activate the T cell unless
appropriate costimulatory factors such as CD80 (B7-1) ordritic cells utilize a first exon that is different from that
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of class II MHC molecules directed by invariant chain. NatureCD86 (B7-2) on the antigen-presenting cells are engaged
348:600–605, 1990
by CD28 on the T cell. Presentation of antigen without 3. Lamb CA, Yewdell JW, Bennink JR, et al: Invariant chain targets
costimulation results in anergy, which has been the case HLA class II molecules to acidic endosomes containing internal-
ized influenza virus. Proc Natl Acad Sci USA 88:5998–6002, 1991reported for renal tubules induced to express class II
4. Cresswell P: Chemistry and functional role of the invariant chain.
[27, 31–33]. We looked for the costimulatory molecules Curr Opin Immunol 4:87–92, 1992
CD80, CD86, and CD40 in normal human kidney but 5. Riberdy JM, Newcomb JR, Surman MJ, et al: HLA-DR molecules
from an antigen-processing mutant cell line are associated withdid not find them on DR-expressing endothelial cells.
invariant chain peptides. Nature 360:474–477, 1992The lack of these costimulatory factors predicts that anti- 6. Guagliardi LE, Koppelman B, Blum JS, et al: Co-localization of
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